| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(84)91567-8 |
| P698 | PubMed publication ID | 6150192 |
| P2093 | author name string | C P Page | |
| J Morley | |||
| S Sanjar | |||
| P2860 | cites work | Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin | Q24672250 |
| Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. | Q35203229 | ||
| Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis | Q35904374 | ||
| Glucocorticoid protection against PAF-acether toxicity in mice | Q36097813 | ||
| Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study | Q39423576 | ||
| Prospects for an oral Intal | Q40261279 | ||
| Present concepts on the mechanisms of platelet aggregation | Q40302756 | ||
| Mechanism of perennial allergic asthma | Q41534392 | ||
| Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids | Q46852044 | ||
| Acute effects of intratracheal administration of platelet-activating factor in baboons. | Q51851881 | ||
| Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. | Q53737562 | ||
| Late cutaneous allergic responses in isolated IgE-dependent reactions | Q54081612 | ||
| Infective factors in exacerbations of bronchitis and asthma | Q68766369 | ||
| CV-3988 - a specific antagonist of platelet activating factor (PAF) | Q70428889 | ||
| Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin | Q70926077 | ||
| Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? | Q71642529 | ||
| Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives | Q72144140 | ||
| Stimulation of alveolar macrophages in asthmatic patients after local provocation test | Q72554094 | ||
| P433 | issue | 8412 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 1142-1144 | |
| P577 | publication date | 1984-11-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | The platelet in asthma. | |
| P478 | volume | 2 |
| Q69882335 | Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man |
| Q38204987 | Acute and long-term pulmonary effects of platelet-activating factor |
| Q69361781 | Airway receptors |
| Q43934572 | Allergen-induced hyperreactivity is not a feature of dermal immediate allergic reactions-in contrast to reactions of airways mucosa |
| Q28609458 | An update on PAF |
| Q41159558 | Anomalous effects of albuterol and other sympathomimetics in the guinea pig. |
| Q34740896 | Asthma -- a need for a rethink? |
| Q40826491 | Bidirectional modulation of platelet and polymorphonuclear leukocyte activities |
| Q33490624 | Bimodal effect of platelet-activating factor (PAF) on airways responsiveness in the rabbit |
| Q37995061 | Chemoprophylaxis in asthma |
| Q68272883 | Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis |
| Q52461862 | Decrease of IgE-dependent platelet activation in Hymenoptera hypersensitivity after specific rush desensitization |
| Q68003316 | Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma |
| Q69893264 | Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man |
| Q67878207 | Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig |
| Q35754957 | Effect of platelet agonists on airway reactivity and intrathoracic platelet accumulation |
| Q69883641 | Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man |
| Q47258971 | Effects of saiboku-to (TJ-96) on the production of platelet-activating factor in human neutrophils |
| Q68111024 | Eosinophil chemotactic activity of topical PAF on the human nasal mucosa |
| Q46173252 | Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation |
| Q33456223 | Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba |
| Q69865033 | Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021 |
| Q33432325 | Is thrombopenia in cord blood indicative of intra-uterine sensitization? |
| Q44131766 | Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig |
| Q38623571 | Lung inflammation, its significance for asthma therapy |
| Q37716696 | Mean platelet volume as an inflammation marker in active pulmonary tuberculosis |
| Q35871174 | Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow |
| Q67807439 | Pharmacological effecs of oral E6123, a novel PAF antagonist, on biological change induced by PAF inhalation in guinea pigs |
| Q93564414 | Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation |
| Q70318623 | Platelet activating factor and asthma |
| Q41125085 | Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol |
| Q44326435 | Platelet aggregation profiles in cluster headache |
| Q44415598 | Platelet and clotting abnormalities in asthma |
| Q47308810 | Platelet-activating factor (PAF) in allergic diseases: Inhibitory effects of anti-allergic drugs, ketotifen and three Kampo medicines on PAF production |
| Q42712073 | Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine |
| Q70015614 | Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells |
| Q39487694 | Platelets in allergy. Assays and interpretation |
| Q53897467 | Platelets in asthma. |
| Q71992610 | Prevention of asthma with ketotifen in preasthmatic children: a three‐year follow‐up study |
| Q35888056 | Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep |
| Q69889202 | Role of plasma exudation in asthmatic airways |
| Q33420733 | Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action |
| Q53901972 | Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
| Q68297075 | Synergistic effect of throm☐ane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils |
| Q42620696 | T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma |
| Q68342809 | The effect of dialyzer reuse on peak expiratory flow rate |
| Q34448081 | The effect of inhaled 5-hydroxytryptamine (5-HT, serotonin) on airway calibre in man. |
| Q67953468 | The effect of platelet activating factor on nasal hypersensitivity |
| Q42566649 | The effect of platelet activating factor on pulmonary beta-adrenoceptors |
| Q46658765 | The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation |
| Q35755135 | The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig |
| Q69886668 | The pathophysiology of bronchial asthma and targets for its drug treatment |
| Q38671704 | The relationship between airway inflammation and bronchial hyperresponsiveness |
| Q38247605 | The role of platelet activating factor in allergic inflammation |
| Q34656136 | The role of platelets in the pathophysiology of asthma. |
| Q33397523 | Venous blood platelets decrease during allergen-induced asthmatic reactions |
Search more.